Firm Logo
215-608-9645

Blog: Mass Torts

  • Roblox’s Safety Overhaul: Progress Arrives Too Late for Countless Families

    Nov 19, 2024

    Roblox, a platform widely celebrated for its popularity among children and teens, has long harbored a darker underbelly. Despite its recent announcement of new safety features aimed at protecting young users, these measures arrive after years of chilling reports detailing how predators, explicit content, and exploitation have infiltrated the platform. For too many families, Roblox became a digital hunting ground where children were exposed to unimaginable harm. While the new safety efforts are a step...
    Read More
  • Safety in the Skies: The Role of Our Courts

    Nov 19, 2024

    The article "Safety in the Skies: The Role of Our Courts," written by Anapol Weiss shareholder Larry E. Coben and published in The Legal Intelligencer, discusses the Ninth Circuit’s recent holding regarding the judiciary's role in adjudicating air traffic control (ATC) negligence claims following aviation tragedies. The Federal Aviation Administration oversees air traffic control, which is generally effective in preventing crashes during takeoff and landing. However, when accidents occur, courts must determine if ATC personnel acted...
    Read More
  • Ozempic and NAOIN – The American Academy of Ophthalmology Issues Statement

    Nov 17, 2024

    “A new study suggests patients taking semaglutide — the active ingredient in Ozempic and Wegovy — may be at higher risk of developing an eye condition that can cause blindness.” That is the first sentence of the American Academy of Ophthalmology (AAO) news release issued in response to the Harvard study published on July 3, 2024 in JAMA Ophthalmology: The eye condition, called non-arteritic anterior ischemic optic neuropathy (“NAION”), happens “when blood flow to the optic nerve...
    Read More
  • Understanding Transvaginal Mesh Complications

    Nov 6, 2024

    Anapol Weiss has been successfully litigating cases involving the use of defective transvaginal mesh (TVM) against various manufacturers, including Johnson & Johnson, Bard, Boston Scientific, and Coloplast. New cases are filed on an ongoing basis because these manufacturers continue to make TVM products even though they have paid enormous amounts out in settlements for women who were injured by TVM products in the past. Purpose of Vaginal Mesh in Medical Procedures Vaginal mesh may be used to...
    Read More
  • Understanding Ozempic Injuries and Your Legal Options for Compensation

    Sep 18, 2024

    Ozempic, a medication commonly prescribed to manage Type 2 diabetes, has gained attention due to its potential side effects and associated health risks. If you or a loved one has experienced injuries caused by Ozempic, it’s important to know that you may be eligible to recover compensation through mass tort litigation. In this blog, we’ll explore what Ozempic is, the injuries it can cause, and how a mass tort lawyer at Anapol Weiss can help you...
    Read More
  • PFAS Contamination in Your Water? Anapol Weiss Can Help You Secure Compensation

    Aug 27, 2024

    The widespread contamination of PFAS (per- and polyfluoroalkyl substances) in drinking water supplies across the United States has sparked significant public health concerns. Often referred to as "forever chemicals," these toxic substances—such as PFOS (perfluorooctane sulfonate) and PFOA (perfluorooctanoic acid)—are linked to life-threatening conditions, including cancer, liver damage, and developmental delays in children. If PFAS contamination in your water supply has caused serious health issues for you or a loved one, the dedicated mass tort...
    Read More
  • Mass Torts Litigation-A Guide To What Makes It Complex

    Aug 1, 2024

    Mass tort litigation is inherently complex due to several factors that distinguish it from individual lawsuits or smaller-scale litigation. Here are some key reasons why mass tort litigation is considered complex: Multiple Plaintiffs: Numerous Victims: In mass tort cases, a large number of individuals may be affected by the same or similar harmful actions, such as exposure to a defective product, environmental pollution, or a pharmaceutical drug. Coordinating and managing the interests of a large group of...
    Read More
  • Juries Send Clear Message to Abbott and Mead Johnson in Premature Infant Formula Trials

    Jul 31, 2024

    Landmark Verdicts Highlight Manufacturer Liability “The sheer size of the plaintiff verdict entered in the second premature infant formula trial late last week was jaw-dropping even to us.” Throughout the country, Anapol Weiss represents the devasted families of premature infants who suffered a severe and often fatal inflammatory bowel disease called necrotizing enterocolitis (NEC) after consuming specialty premature infant formulas and fortifiers in the NICU. Anapol Weiss also holds a leadership position in the federal multidistrict litigation...
    Read More
  • Our Commitment to Provide Personal Attention to Our Mass Tort Clients

    Jul 25, 2024

    In mass tort litigations, where hundreds, if not thousands, of plaintiffs join together to seek justice against a common defendant/product, the concept of personal attention often seems antithetical. One of the most common concerns I hear from mass tort clients is that they don’t want to feel like a number in a sea of legal proceedings. They want their story told, they want their injury and complications understood, and they want to convey the impact...
    Read More
  • When Your Personal Health Information Has Been Mishandled

    Jul 16, 2024

    Patients trust that when they disclose their personal identifying information (PII) and protected health information (PHI) including name, date of birth, social security number, address, race, gender, and health insurance information, among others, in furtherance of healthcare services, providers and their subcontractors and vendors that have access to these records, will maintain the upmost care and caution in storing this valuable PII and PHI, and keep this information confidential. Data security is imperative and when...
    Read More